Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Post-finasteride syndrome's existence is uncertain; more research needed.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Skin aging reflects overall body aging and can indicate internal health conditions.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Skin-sparing techniques in gynecomastia surgery lead to good chest results and high patient satisfaction with less scarring.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.